SP3 and prostate carcinoma: Although androgen can mediate the upregulation of VEGF expression in androgen-dependent prostate cancer cells through the Sp1/Sp3 binding site in the VEGF core promoter [28], it was not previously known how PPARγ exactly up-regulated VEGF in prostate cancer cells.